Zimmermann Martin M

Show results for

Unknown (126)
Metabolomics (12)
Proteomics (5)
Transcriptomics (2)

Organisms

Alphavirus (3)
Anemia (3)
Betaherpesvirinae (3)
Borrelia (3)
Cowpox virus (3)
Coxsackievirus (3)
Cytomegalovirus (3)
Dengue virus (3)
EFO:0001352 (3)
Filoviridae (3)
Hepatitis B virus (3)
Human alphaherpesvirus 1 (3)
Human betaherpesvirus 5 (3)
Human immunodeficiency virus (3)
Human immunodeficiency virus 1 (3)
Human immunodeficiency virus 2 (3)
Influenza A virus (3)
Influenza C virus (3)
Japanese encephalitis virus group (3)
Lyssavirus rabies (3)
Middle East respiratory syndrome-related coronavirus (3)
Monkeypox virus (3)
Orthopoxvirus (3)
Orthopoxvirus vaccinia (3)
Rattus (3)
Staphylococcus aureus (3)
Streptococcus pneumoniae (3)
Viruses (3)
West Nile virus (3)
Homo sapiens (2)

Repository

MetaboLights (12)
pride (3)
biostudies-arrayexpress (2)
MassIVE (1)
PanoramaPublic (1)

Tissue

Amnion (1)
Cell suspension culture (1)
Fetal membrane (1)
Oocyte (1)

Disease

Malignant neoplasm of ovary (1)

Technology Type

Mass spectrometry (12)
Mass Spectrometry (3)
Shotgun proteomics (3)

Instrument Platform

Liquid Chromatography MS - negative - direct infusion (2)
Liquid Chromatography MS - positive - reverse phase (2)
4000 QTRAP (1)
QTRAP 5500 (1)
TSQ Vantage (1)
QTRAP 4000 negative (AB Sciex) (1)
QTRAP 4000 positive (AB Sciex) (1)
Orbitrap velos HCD negative (Thermo Scientific) (1)
Orbitrap velos HCD positive (Thermo Scientific) (1)
Orbitrap velos CID negative (Thermo Scientific) (1)
Orbitrap velos CID positive (Thermo Scientific) (1)
Liquid Chromatography MS – HILIC (1)
Liquid Chromatography MS - HILIC (1)
LTQ-FT (Thermo) (1)
QExactive negative (Thermo Scientific) (1)
QExactive positive (Thermo Scientific) (1)
QTOF G6550A negative (Agilent) (1)
QTOF G6550A positive (Agilent) (1)
QTRAP 6500 negative (AB Sciex) (1)
QTRAP 6500 positive (AB Sciex) (1)
Orbitrap elite negative (Thermo Scientific) (1)
Orbitrap elite positive (Thermo Scientific) (1)
Diode array detection MS - (1)
Biological experiment negative - QTRAP 4000 (AB Sciex) (1)
Biological experiment positive - QTRAP 4000 (AB Sciex) (1)
Biological experiment negative - Orbitrap velos CID (Thermo Scientific) (1)
Biological experiment positive - Orbitrap velos CID (Thermo Scientific) (1)
Control experiment 1 negative - Orbitrap velos CID (Thermo Scientific) (1)
Control experiment 1 positive - Orbitrap velos CID (Thermo Scientific) (1)
Liquid Chromatography MS - (1)

Publication Date

2021 (8)
2014 (4)
2019 (2)
2017 (2)
2022 (1)
2023 (1)

CHEBI ID

CHEBI:16750 (3)
CHEBI:17596 (3)
CHEBI:17001 (2)
CHEBI:17111 (2)
CHEBI:2247 (2)
CHEBI:18337 (2)
CHEBI:15811 (2)
CHEBI:18066 (2)
CHEBI:138560 (2)
CHEBI:17256 (2)
CHEBI:17659 (2)
CHEBI:15414 (2)
CHEBI:16040 (2)
CHEBI:17239 (2)
CHEBI:17275 (2)
CHEBI:16742 (2)
CHEBI:17562 (2)
CHEBI:17515 (2)
CHEBI:15428 (2)
CHEBI:16119 (2)
CHEBI:17015 (2)
CHEBI:17196 (2)
CHEBI:16335 (2)
CHEBI:17568 (2)
CHEBI:17509 (2)
CHEBI:16467 (2)
CHEBI:18107 (2)
CHEBI:15971 (2)
CHEBI:16474 (2)
CHEBI:30797 (2)

Metabolite Name

Accurate mass (2)
Shikimate (2)
Glycine (2)
Orotate (2)
7,8-Diaminononanoate (2)
Gamma-L-Glutamyl-L-cysteine (2)
DCMP (2)
L-Arginine (2)
L-Asparagine (2)
L-Histidine (2)
Indole (2)
Xanthosine (2)
Adenosine (2)
Cytosine (2)
Riboflavin (2)
L-Tryptophan (2)
L-Phenylalanine (2)
Inosine (2)
PI 40:6|PI 40:6|-|-|-|-|PI 40:6|-|-|PI 40:6|-|-|-|-|- (1)
-|-|-|-|-|PI 40:5|-|-|-|-|-|-|-|PI 40:5|- (1)
-|PI 40:4|-|-|-|-|-|-|PI 40:4|-|-|-|-|-|- (1)
-|-|PI 39:4|-|-|-|-|-|-|-|PI 20:4_19:0|-|PI 20:4_19:0|-|PI 20:4_19:0 (1)
-|-|-|-|-|-|-|-|PI 38:6|-|-|-|-|-|- (1)
-|PI 38:5|-|-|PI 38:5|PI 38:5|PI 38:5|PI 38:5|-|-|PI 38:5|PI 20:5_18:0|PI 20:5_18:0|PI 20:5_18:0|- (1)
PI 18:1/20:4|PI 18:1/20:4|PI 18:1/20:4|PI 18:1_20:4|PI 18:1/20:4|PI 38:5|PI 18:1/20:4|PI 18:1/20:4|PI 18:1_20:4|PI 18:1/20:4|PI 18:1/20:4|PI 18:1_20:4|PI 18:1/20:4|PI 18:1/20:4|PI 18:1/20:4 (1)
PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4|PI 18:0/20:4 (1)
PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 18:0/20:3|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0|PI 20:3_18:0 (1)
PI 20:4_17:0|PI 20:4_17:0|PI 20:4_17:0|-|PI 20:4_17:0|PI 37:4|PI 20:4_17:0|-|-|-|PI 20:4_17:0|-|PI 20:4_17:0|PI 20:4_17:0|PI 20:4_17:0 (1)
PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4|PI 16:0/20:4 (1)
PI 36:3|PI 36:3|-|-|PI 36:3|PI 20:3_16:0|-|-|PI 20:3_16:0|PI 36:3|-|PI 36:3|-|PI 20:3_16:0|PI 36:3 (1)

Study type

Transcription profiling by array (2)

Release Date

2022 (20)
2021 (18)
2024 (13)
2023 (12)
2025 (11)
2017 (8)
2016 (8)
2018 (7)
2020 (6)
2019 (5)
2015 (5)
2014 (4)
2026 (3)
2011 (2)
2010 (2)
2005 (2)
2008 (1)
2007 (1)

Lab affiliation

Department of Molecular and Cellular Pharmacology University of California San Francisco (1)
Department of Obstetrics, University and University Hospital of Zurich, Zurich, Switzerland (1)
Pediatric Hematology and Oncology, Martin-Luther-University Halle-Wittenberg, 06120 Halle, Germany (1)

Previous page
1 / 15
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 15
Next page

Sort by:

Relevance

Page size

Approaches for the treatment of perforated peptic ulcers: a network meta-analysis of randomized controlled trials.

Not available

S-EPMC12413338 | biostudies-literature

Approaches for the treatment of perforated peptic ulcers: a network meta-analysis of randomised controlled trials - study protocol.

Not available

S-EPMC10953088 | biostudies-literature

The risk of indoor sports and culture events for the transmission of COVID-19.

Not available

S-EPMC8376924 | biostudies-literature

Interventions to reduce the incidence of surgical site infection in colorectal resections: systematic review with multicomponent network meta-analysis (INTRISSI): study protocol.

Not available

S-EPMC8627408 | biostudies-literature

CMK LC-MS/MS after CoIP of ARID3A

In order to determine proteins interacting with ARID3A in the ML-DS cell line CMK, we performed CoIP of endogenous ARID3A followed by LC-MS/MS

ORGANISM(S): Homo sapiens (Human)

2023-03-11 | PXD025027 | Pride

A continuous sirtuin activity assay without any coupling to enzymatic or chemical reactions.

Not available

S-EPMC4778124 | biostudies-literature

Homeostasis of the biosynthetic E. coli metabolome

Metabolite concentrations vary across conditions and such metabolome changes are relevant for metabolic and gene regulation. Here, we used LC-MS/MS to explore metabolite concentration changes in Escherichia coli. We measured 101 primary metabolites in 19 experimental conditions that include v...

2022-11-02 | MTBLS4249 | MetaboLights

Snoezelen, structured reminiscence therapy and 10-minutes activation in long term care residents with dementia (WISDE): study protocol of a cluster randomized controlled trial.

Not available

S-EPMC2843691 | biostudies-literature

Cold exposure induces dynamic changes in circulating triacylglycerol species, which is dependent on intracellular lipolysis: A randomized cross-over trial.

Not available

S-EPMC9663865 | biostudies-literature

Bioaccumulation of therapeutic drugs by human gut bacteria (L.saccharolytica;Standards assays)

Bacteria in the gut can modulate the availability and efficacy of therapeutic drugs. Interactions at this level have only recently started to being systematically mapped and the main underlying mechanism proposed is chemical transformation of drugs by microbes (biotransformation). Here, we invest...

2021-07-20 | MTBLS2885 | MetaboLights

Previous page
1 / 15
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 15
Next page

Sort by:

Relevance

Page size

145 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets